Clarence W. Legerton

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

P. Emery, Patrick Durez, M Dougados et al. · Annals of the Rheumatic Diseases · 2009 · 257 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

M. C. Genovese, A. Covarrubias, G. Léon et al. · Arthritis & Rheumatism · 2011 · 195 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial

Mark C. Genovese, César Pacheco‐Tena, Gustavo León et al. · The Journal of Rheumatology · 2018 · 38 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Mechanism of Pain in Peptic Ulcer

Julian M. Ruffin, George J. Baylin, Clarence W. Legerton et al. · Gastroenterology · 1953 · 36 citations

Medicine, Surgery, Pain Management +11